MAPT and Alzheimer disease: It is crucial to emphasize that the initial detection of positive Tau-PET within the inner temporal cortex, lacking concurrent positive Aβ biomarkers, does not warrant classification as pre-clinical AD under the current criteria established by NIA-AA, which fits with the principles of the amyloid cascade hypothesis.